ESC Premium Access

Vascular protection - Which of your patients with chronic coronary artery disease will benefit?

Event: ESC CONGRESS 2019
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Session type: Satellite Symposium
Sponsored by Bayer AG
Date: 2 September 2019
Time: 13:00 - 14:00

Congress Session

5 presentations in this session

Welcome and introduction

Speaker: Professor K. Fox (Edinburgh, GB)
Thumbnail

Myth of stable coronary artery disease: Learnings from clinical practice

Speaker: Professor P. Steg (Paris, FR)
Thumbnail

Intensified antithrombotic treatment for chronic coronary artery disease - Applying the data to your patients

Speaker: Doctor J. Eikelboom (Hamilton, CA)
Thumbnail

Case clinic - Treating the patient who needs more

Speaker: Professor G. Montalescot (Paris, FR)
Speaker: Professor R. Welsh (Edmonton, CA)
Thumbnail

Questions and answers and closing remarks - Vascular protection

Speaker: Professor K. Fox (Edinburgh, GB)
Thumbnail

6 speakers from this session

Professor Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
36 presentations
0 follower

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
47 presentations
2 followers

Doctor John William Eikelboom

McMaster University, Hamilton (Canada)
34 presentations
0 follower

Professor Gilles Montalescot

Sorbonne University, Paris (France)
24 presentations
1 follower

Professor Robert Welsh

Mazankowski Alberta Heart Institute, Edmonton (Canada)
15 presentations
0 follower

Professor Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
36 presentations
0 follower

This platform is supported by

logo Novo Nordisk